Home / Inspections / 908088

FDA Inspection 908088 — Roswell Park Cancer Institute Corporation. Div. Of Pathology

Roswell Park Cancer Institute Corporation. Div. Of Pathology — FEI 1372120

The FDA completed an inspection of Roswell Park Cancer Institute Corporation. Div. Of Pathology on Dec 19, 2014 in Buffalo, NY. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI)
End Date
Dec 19, 2014
Fiscal Year
2015
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Buffalo, NY (United States)

Facility

Other inspections at this facility

FDA data resources

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.